Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01059968 · ClinicalTrials.gov registry record

Low Energy Availability, Menstrual Irregularity, and Low Bone Mass

A clinical trial of Bone Density and Energy Availability, sponsored by USDA, Western Human Nutrition Research Center.

Completed
Registry status
45
Enrollment target
1
Study location

NCT01059968: Completed study of Bone Density and Energy Availability, sponsored by USDA, Western Human Nutrition Research Center.

NCT01059968 is a study of Bone Density and Energy Availability that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 45 participants, below the 3,761-participant average among 7 other Bone Density trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01059968, a study of Bone Density and Energy Availability, has completed, sponsored by USDA, Western Human Nutrition Research Center.

COMPLETED
Registry status
45 participants
Enrollment target
1
Study location

Study Summary

This study examines the role of energy availability on menstrual function and bone mass in female adolescent endurance athletes. Specific evaluations include dietary intake, exercise energy expenditure, training schedules, menstrual function and bone density.

Study Locations (1)

California

  • Marta Van Loan - Davis

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2008-09
Est. Completion 2009-12

What the finished NCT01059968 record still lists

NCT01059968 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 3,761-participant average among 7 other Bone Density trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Bone Density appearing as the primary indexed condition, and to 0 interventions.

NCT01059968 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01059968 about?

NCT01059968 is a clinical study titled "Low Energy Availability, Menstrual Irregularity, and Low Bone Mass". This study examines the role of energy availability on menstrual function and bone mass in female adolescent endurance athletes. Specific evaluations include dietary intake, exercise energy expenditure, training schedules, menstrual function and bone density.

What is the current status of trial NCT01059968?

This trial is currently completed. The enrollment target is 45 participants. The study started on 2008-09. Estimated completion is 2009-12.

What conditions does trial NCT01059968 study?

This clinical trial studies the following conditions: Bone Density, Energy Availability.

Who is sponsoring clinical trial NCT01059968?

This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01059968 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bone Density

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01059968, the US trial registry maintained by the National Library of Medicine. NCT01059968 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.